PRODUCT DETAILS
  • Home
  • product details

Chemofit

composition
Tab. Gefitinib IP 250 mg

indications
Metastatic non-small cell lung cancer (NSCLC)

Therapeutic Focus
Oncology

More Oncology Products

Avastimab Formulation
Bulalfa Formulation
Hermab Formulation
Nabpac Formulation
Neosez Formulation
Rivorca Formulation
Zestmab Formulation
Abitate Formulation
Anarzole Formulation
Arpimune-O Formulation
Azaplast Formulation
Bortemap Formulation
Carbozar Formulation
Docel Formulation
Emcitaben Formulation
Erubin Formulation
Fixpritant Formulation
Fospritant Formulation
Frastim Formulation
Neomustin Formulation
Neoxal Formulation
Peg Frastim Formulation
Pemexar Formulation
Temotide Formulation
Timinib Formulation
Xecap Formulation
Z pac Formulation
Zubidox Formulation